Patients benefiting from a supercharged clinical research system

Patients across the UK will benefit from a supercharged clinical research system backed by a £ 175m dedicated investment that saves lives across the country.

The UK-wide plan announced today (Thursday, June 30) will enable innovative research to be conducted more quickly, giving patients faster access to cutting-edge treatments and accelerating diagnosis. And the backlog of Covid will be cleared. It will be:

• Increase the amount and workforce of research and put the UK at the center of cutting-edge global clinical research
• Improve the quality of research by increasing responsibility and accountability for NHS-wide research
• Make sure your research addresses the needs and challenges facing the NHS, including improved inclusiveness and accessibility.
• Take opportunities outside the EU to relax regulations and enable safe, fast and flexible research
• Improve UK-wide research participation by investing in digital-focused trials

This further strengthens the UK’s position as a global leader in the delivery of life sciences and clinical research, following the successful development and deployment of the Covid vaccine.

£ 150m additional funding from the National Institute for Health and Care (NIHR) to set up a second phase of work from 2022 to 2025 to achieve the future vision of UK clinical research delivery And 25 pounds are included. 1 million additional funding from other delivery partners in the UK Clinical Research Recovery, Resilience and Growth Program.

The second phase builds on work already done, such as halving the approval time for new clinical trials.

The £ 175 million investment to strengthen the data infrastructure of the delegated government to enable better research and solidify Britain’s position as a global life sciences superpower. In addition to the up to £ 200 million announced earlier this year.

Continued investment means that clinical trials can be conducted more quickly with an enhanced workforce and improved technology, effectively helping patients participate. This is already benefiting the UK as a whole, including providing antiviral treatments to protect vulnerable people from Covid.

Sajid Javid, Minister of Health, said:

We improve the health care of patients across the UK by delivering cutting-edge scientific developments, increasing the workforce and providing the world’s leading professionals with the tools they need to harness digital innovation. We are strengthening clinical research for.

As a global life science superpower, we have been a world leader in vaccines and antiviral treatments. Today’s plans ensure that we are at the forefront of clinical research to save lives and eliminate Covid’s backlog. “

Sir Kamal, Minister of Innovation and Life Sciences, said:

Our world-leading scientists and clinicians have repeatedly proved to be at the forefront of innovation and scientific progress during the Covid pandemic.

We will continue to support these by providing the funding, infrastructure, and workforce needed for cutting-edge clinical research that ultimately saves lives.

Working together will protect the NHS, reduce backlog, and enable patients to benefit from rapid and safe clinical research. “

Significant advances in strengthening research already include:

• Halve the approval period for new clinical trials, start faster and more innovative new research, and enable faster discovery
• Launch a new UK-wide expert certification system for clinical research practitioners to double the size of this critical workforce and enable more research.
• Investing £ 200 Million in UK Health Data Infrastructure to Strengthen Delegated Government Data Infrastructure to Enable Better Research

Covid’s antiviral treatment PANORAMIC trials and IBS-D people manage symptoms and live.

Professor Lucy Chappell, Chief Executive Officer of NIHR, said:

I am pleased to be able to work with such strong, cross-disciplinary partnerships to transform the future of research delivery.

We all want to make a real difference for patients and researchers. These plans demonstrate a common commitment to strengthen our commitment to efficient, innovative and patient-centric research to address future healthcare and care challenges. “

Robin Swann, Northern Ireland Executive Minister of Health, said:

The recommendations contained in this plan will be strengthened on the basis of the significant contributions Northern Ireland has already made to local, UK and global research.

They are with community leadership, the commitment of our health and social care staff to ensure that patients are offered and supported through the trials, and the citizens who participate in these studies. Take advantage of your partner’s willingness. The study is essential to the practice of health and social care, and the resilience, resilience and growth of this study are essential to improving the health and well-being of the people of Northern Ireland. This new plan provides us with the foundation to achieve this. “

Humza Yousaf, Chief Cabinet Secretary of Health and Social Welfare, Scottish Government, said:

The UK’s clinical research strategy, announced last year, has set out an ambitious vision for realizing the true potential of clinical research. Last year, we worked with partners across the research community, across the country, and across the sector to promote the common goal of a more innovative and resilient research system with clinical research integrated into the NHS.

This is essential for the NHS’s recovery, and the Phase 2 plan announced today sets out the key areas for the next three years. Scotland is proud to be able to participate in this work. Leveraging the strengths of collaborative research across the UK, we can realize our vision, shape the future of healthcare and improve people’s lives in the coming years. “

Eluned Morgan, Minister of Health and Social Services of the Government of Wales, said:

The UK clinical research strategy announced last year was an important catalyst for new ways of working to drive the research agenda across the UK, out of the pandemic.

Wales is proud to be an important partner in increasing the resilience of its research department, incorporating research into the NHS, and driving innovation to improve care, welfare and treatment here in Wales and beyond. increase.

Working with other delegating countries and Healthcare Research in Wales to support life sciences agendas, address health inequality and promote these ambitious plans to improve the health of people across the UK. I’m looking forward to it. “